V
Virax Biolabs Group Ltd
NASDAQ:VRAX
Virax Biolabs Group Ltd
NASDAQ:VRAX
Price:
0.22
USD
-9.09%
Market Closed
Market Cap:
$1.6m
Income Statement
Earnings Waterfall
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd
Income Statement
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd
Currency: USD
| Mar-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
+822%
|
0
+97%
|
0
-46%
|
0
-93%
|
0
-52%
|
|
| Gross Profit | ||||||||
| Cost of Revenue |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+462%
|
0
-34%
|
(0)
N/A
|
(0)
+15%
|
|
| Operating Income | ||||||||
| Operating Expenses |
(2)
|
(6)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
|
| Selling, General & Administrative |
(1)
|
(5)
|
(6)
|
(5)
|
(4)
|
(4)
|
(3)
|
|
| Research & Development |
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Operating Income |
(2)
N/A
|
(6)
-231%
|
(7)
-22%
|
(6)
+13%
|
(6)
-3%
|
(6)
+2%
|
(6)
+5%
|
|
| Pre-Tax Income | ||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(2)
N/A
|
(5)
-212%
|
(7)
-27%
|
(7)
+3%
|
(7)
+0%
|
(6)
+8%
|
(6)
+4%
|
|
| Net Income | ||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(2)
|
(5)
|
(7)
|
(7)
|
(7)
|
(6)
|
(6)
|
|
| Income to Minority Interest |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(2)
N/A
|
(5)
-219%
|
(7)
-27%
|
(7)
+3%
|
(7)
+2%
|
(6)
+8%
|
(6)
+7%
|
|
| EPS (Diluted) |
-0.15
N/A
|
-5.13
-3 320%
|
-3.89
+24%
|
-3.36
+14%
|
-2.12
+37%
|
-1.62
+24%
|
-1.18
+27%
|
|
Switch to:
Switch to:
See Also
Discover More
